Have a feature idea you'd love to see implemented?
Let us know!
TYRA Tyra Biosciences Inc
Price (delayed)
$15.36
Market cap
$777.26M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.61
Enterprise value
$678.69M
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective
Highlights
Tyra Biosciences's equity has surged by 63% YoY but it has decreased by 3.7% QoQ
Tyra Biosciences's quick ratio has increased by 37% YoY but it has decreased by 19% from the previous quarter
TYRA's net income is down by 41% YoY and by 3.5% QoQ
The debt is up by 3.4% year-on-year
Key stats
What are the main financial stats of TYRA
Market
Valuations
Earnings
Shares outstanding
50.6M
Market cap
$777.26M
Enterprise value
$678.69M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$83.74M
EBITDA
-$83.26M
Free cash flow
-$64.98M
Per share
Balance sheet
Liquidity
EPS
-$1.61
Free cash flow per share
-$1.1
Book value per share
$6.86
Revenue per share
$0
TBVPS
$6.46
Total assets
$380.59M
Total liabilities
$18.3M
Debt
$6.32M
Equity
$362.29M
Working capital
$353.24M
Debt to equity
0.02
Current ratio
29.55
Quick ratio
29.19
Net debt/EBITDA
1.18
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-23.9%
Return on equity
-25.1%
Return on invested capital
-38.8%
Return on capital employed
-22.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TYRA stock price
How has the Tyra Biosciences stock price performed over time
Intraday
-3.21%
1 week
-6%
1 month
-45.86%
1 year
38.88%
YTD
10.9%
QTD
-34.67%
Financial performance
How have Tyra Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$100.09M
Net income
-$83.74M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 44% YoY and by 4.9% from the previous quarter
TYRA's net income is down by 41% YoY and by 3.5% QoQ
Growth
What is Tyra Biosciences's growth rate over time
Valuation
What is Tyra Biosciences stock price valuation
P/E
N/A
P/B
2.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 17% year-on-year but it is up by 4.7% since the previous quarter
Tyra Biosciences's equity has surged by 63% YoY but it has decreased by 3.7% QoQ
The P/B is 17% below the last 4 quarters average of 2.7
Efficiency
How efficient is Tyra Biosciences business performance
The return on invested capital has surged by 91% year-on-year and by 27% since the previous quarter
The ROA has grown by 7% from the previous quarter
The ROE has grown by 7% from the previous quarter but it has contracted by 2.4% YoY
Dividends
What is TYRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TYRA.
Financial health
How did Tyra Biosciences financials performed over time
The total assets has soared by 60% YoY but it has contracted by 3% from the previous quarter
Tyra Biosciences's quick ratio has increased by 37% YoY but it has decreased by 19% from the previous quarter
The debt is 98% smaller than the equity
Tyra Biosciences's equity has surged by 63% YoY but it has decreased by 3.7% QoQ
The debt to equity has declined by 33% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.